Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John H Stone, M.D.

Co-Author

This page shows the publications co-authored by John Stone and Paul Dellaripa.
Connection Strength

0.236
  1. Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis. Arthritis Rheumatol. 2018 12; 70(12):2077-2086.
    View in: PubMed
    Score: 0.049
  2. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Arthritis Rheumatol. 2017 05; 69(5):1054-1066.
    View in: PubMed
    Score: 0.044
  3. Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthritis Rheum. 2013 Sep; 65(9):2457-68.
    View in: PubMed
    Score: 0.034
  4. Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis. Arthritis Rheum. 2012 Oct; 64(10):3463-71.
    View in: PubMed
    Score: 0.032
  5. IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis. Proc Natl Acad Sci U S A. 2011 Dec 20; 108(51):20736-41.
    View in: PubMed
    Score: 0.030
  6. Alpha1-antitrypsin deficiency-related alleles Z and S and the risk of Wegener's granulomatosis. Arthritis Rheum. 2010 Dec; 62(12):3760-7.
    View in: PubMed
    Score: 0.028
  7. Domains of health-related quality of life important to patients with giant cell arteritis. Arthritis Rheum. 2003 Dec 15; 49(6):819-25.
    View in: PubMed
    Score: 0.018
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.